SG's Allozymes raises $5m seed funding led by Temasek unit Xora Innovation

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S., on Wednesday, Feb. 8, 2012. Photographer: David Paul Morris/Bloomberg

Singapore-based synthetic biology startup Allozymes has raised $5 million in seed funding led by Xora Innovation, the deep science investment arm of Temasek Holdings. The round was also joined by SOSV, TI Platform Management and Entrepreneur First.

Allozymes was founded in 2019 by Peyman Salehian and Akbar Vahidi, two PhD scientists from the National University of Singapore. It focuses on enzyme engineering, which Allozymes believes will play an increasingly crucial role in the bio-manufacturing of industrial ingredients across food, pharma, cosmetics and fuel sectors.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter